Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 2015

View Archived Issues

60 Degrees Pharmaceuticals and Singapore General Hospital to test celgosivir in dengue fever

Novel aldosterone synthase inhibitors active in monkeys

Researchers detail preclinical evaluation of altiratinib

Regenerative peptide mitigates radiation-induced gastrointestinal damage

Preclinical efficacy of a human monoclonal antibody against influenza A virus

Preclinical results presented for IKur inhibitor BMS-919373

Advaxis and MedImmune start phase I/II trial combining ADXS-HPV and durvalumab

FDA grants orphan drug designation to SER-109 for CDI in adults

AAK1 inhibitor shows potential for the treatment of neuropathic pain

Raptor Pharmaceutical to acquire inhaled fluoroquinolone therapy for cystic fibrosis

Eteplirsen granted FDA rare pediatric disease designation for DMD

Vital Therapies releases topline data from phase III trial of ELAD

TiGenix's Cx-601 achieves primary endpoint in pivotal fistula trial

Northwest Biotherapeutics confirms status of phase III trial of DCVax-L in glioblastoma multiforme

Pfizer releases topline data from phase III studies of Trumenba

Merck & Co. discloses FFAR1 agonists

Cognition Therapeutics patents sigma-2 receptor antagonists

Shijiazhuang Yiling Pharmaceutical divulges VEGFR-2 inhibitors

FDA review of Aristada ongoing

Genentech and Roche disclose anti-influenza MAbs

Peregrine and AstraZeneca collaborate to conduct bavituximab and durvalumab combination study

Lilly files for approval of ixekizumab in Japan

C4 Imaging receives NCI grant to develop MRI/CT imaging marker

Motif Bio's iclaprim shows in vitro efficacy against S. aureus

Banner MD Anderson studies olaparib for pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...